Cargando…

Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study

SIMPLE SUMMARY: The role of radiotherapy in the treatment of perihilar cholangiocarcinoma has not yet been properly defined. In this prospective study, we therefore explored the addition to first-line chemotherapy of stereotactic body radiation therapy (SBRT) delivered in 15 fractions. Patients elig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baak, Rogier, Willemssen, François E. J. A., van Norden, Yvette, Eskens, Ferry A. L. M., Milder, Maaike T. W., Heijmen, Ben J. M., Koerkamp, Bas Groot, Sprengers, Dave, van Driel, Lydi M. J. W., Klümpen, Heinz-Josef, den Toom, Wilhelm, Koedijk, Merel S., IJzermans, Jan N. M., Méndez Romero, Alejandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394718/ https://www.ncbi.nlm.nih.gov/pubmed/34439146 http://dx.doi.org/10.3390/cancers13163991

Ejemplares similares

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study
por: Koedijk, Merel S, et al.
Publicado: (2018)

Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial
por: Paronetto, Chiara, et al.
Publicado: (2023)

Nationwide treatment and outcomes of perihilar cholangiocarcinoma
por: van Keulen, Anne‐Marleen, et al.
Publicado: (2021)

Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis
por: de Jong, David M., et al.
Publicado: (2022)

Evaluation of the New American Joint Committee on Cancer Staging Manual 8th Edition for Perihilar Cholangiocarcinoma
por: Gaspersz, Marcia P., et al.
Publicado: (2019)

Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
por: de Jong, David M., et al.
Publicado: (2023)

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study
por: Hoogwater, Frederik J H, et al.
Publicado: (2023)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022)

Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions
por: Kamani, Lubna, et al.
Publicado: (2020)

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience
por: Rassam, F., et al.
Publicado: (2018)

Largely reduced OAR doses, and planning and delivery times for challenging robotic SBRT cases, obtained with a novel optimizer
por: Giżyńska, Marta K., et al.
Publicado: (2021)

Klatskin tumor presenting as unresectable perihilar hepatic mass: A case report
por: Yehouenou Tessi, Thierry Romeo, et al.
Publicado: (2021)

Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma
por: Roos, Eva, et al.
Publicado: (2019)

Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy
por: van Doorn, Diederick J., et al.
Publicado: (2021)

Irreversible Electroporation Treatment With Intraoperative Biliary Stenting for Unresectable Perihilar Cholangiocarcinoma: A Pilot Study
por: Yang, Po-Chih, et al.
Publicado: (2021)

Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation
por: Azad, Adiba I., et al.
Publicado: (2020)

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
por: Suker, Mustafa, et al.
Publicado: (2018)

Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review
por: Franken, L. C., et al.
Publicado: (2019)

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
por: Nooijen, Lynn E., et al.
Publicado: (2022)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Preoperative Management of Perihilar Cholangiocarcinoma
por: Ellis, Ryan J., et al.
Publicado: (2022)

Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma
por: Hewitt, D. Brock, et al.
Publicado: (2022)

Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors
por: Rossi, Linda, et al.
Publicado: (2019)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol
por: Coelen, Robert J S, et al.
Publicado: (2017)

The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma
por: van Keulen, Anne-Marleen, et al.
Publicado: (2023)

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2022)

Inside Plastic Stents versus Metal Stents for Treating Unresectable Malignant Perihilar Biliary Obstructions: A Retrospective Comparative Study
por: Kanno, Yoshihide, et al.
Publicado: (2020)

Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT
por: Magallon-Baro, Alba, et al.
Publicado: (2022)

The role of EUS in diagnosis and treatment of liver disorders
por: Campos, Sara, et al.
Publicado: (2019)

Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned
por: de Brabander, Justin, et al.
Publicado: (2018)

The yield of chest computed tomography in patients with locally advanced pancreatic cancer
por: Suker, Mustafa, et al.
Publicado: (2020)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Vascular Resection in Perihilar Cholangiocarcinoma
por: Serrablo, Alejandro, et al.
Publicado: (2021)

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group
por: Ruzzenente, Andrea, et al.
Publicado: (2021)

Author response to: Comment on: Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
por: Buettner, Stefan, et al.
Publicado: (2023)

Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?
por: van Keulen, Anne-Marleen, et al.
Publicado: (2021)

ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma
por: Holster, Jessica J., et al.
Publicado: (2022)

Perihilar-cholangiocarcinoma: what really matters?
por: Di Benedetto, Fabrizio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7kdqj60o07boa8mc2qp6ubbakk